Acquisition
Ampersand Capital Partners Aquired Nektar Therapeutics' PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem
Ampersand Capital Partners
PR-12-24-NI-121Dec 02, 2024
Axonics
Boston Scientific Closes Acquisition of Axonics, Inc.
Boston Scientific
PR-11-24-NI-105Nov 15, 2024
Vantage Nutrition LLC Acquires ComboCap Inc
Vantage Solutions
PR-M03-23-07Mar 27, 2023
Acquisition and Rebranding
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
AcuraBio
PR-M09-22-01Sep 07, 2022
M&A
Novo Holdings Portfolio Company ReViral to be Acquired by Pfizer
Novo Holdings A/S
PR-M04-22-05Apr 07, 2022
M&A
TriRx Completes Acquisition of Elanco Manufacturing Facility in Speke, United Kingdom
TriRx Pharmaceutical Services
PR-M02-22-06Feb 08, 2022
Facility Acquisition
Fujifilm Expands its Advanced Therapies CDMO Business with the Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
Fujifilm Biotechnologies
PR-M01-22-18Jan 26, 2022
New Facility
TriRx Hosted State and Community Leaders to Celebrate Acquisition of Shawnee, Kansas Facility
TriRx Pharmaceutical Services
PR-M07-21-013Aug 11, 2021
Acquisition
TriRx Completes Acquisition of Elanco Animal Health Facility in Shawnee, Kansas
TriRx Pharmaceutical Services
PR-M08-21-01Aug 02, 2021
Facility Acquisition
TriRx Enters Agreement for the Acquisition of Elanco Animal Health Facilities in Shawnee, Kansas and Speke, United Kingdom
TriRx Pharmaceutical Services
PR-M06-21-019Jun 15, 2021
Acquisition
Grifols Reinforces its Innovation Strategy After Completing the Acquisition of GigaGen to Boost a Novel Method to Generate a Wide Range of Immunoglobulins
Grifols
PR-M11-20-045Mar 09, 2021
WuXi AppTec Completes Acquisition of OXGENE to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers
WuXi AppTec
PR-M11-20-040Mar 02, 2021
Acquisition
Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep
Thermo Fisher Scientific
PR-M11-20-035Jan 15, 2021
M&A
AbCellera Expands Technology Stack with Acquisition of Trianni for $90 Million
AbCellera Biologics Inc.
PR-M11-20-018Nov 19, 2020